PARALLAX HEALTH SCIENCES, INC.: 10-Q/A filed 2019-12-13
What PARALLAX HEALTH SCIENCES, INC. reported in its quarterly report amendment filed 2019-12-13 (fiscal Q3 2019): 34 published measures, 95 facts as tagged in accession 0001388410-19-000173.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2019-12-13
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001388410-19-000173 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All PARALLAX HEALTH SCIENCES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,373,305 | USD | |
| At 2018-12-31 | 1,364,357 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 7,208,718 | USD | |
| At 2018-12-31 | 7,314,811 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -4,835,413 | USD | |
| At 2018-12-31 | -5,950,454 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 11,973 | USD | |
| At 2018-12-31 | 262 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -2,460,308 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -6,458,279 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 25,074,058 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 17,255,884 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 25,855 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 77,745 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 990 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 10,749 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -2,628 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -25,649,201 | USD | |
| At 2018-12-31 | -19,190,922 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 218,115,643 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 190,038,071 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 149,431,153 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 146,294,981 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 262,011,413 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 233,933,841 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 208,254,652 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 205,118,481 | shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,408 | USD | |
| At 2018-12-31 | 0 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 2,572,741 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 3,152,943 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -1,916,035 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,138,214 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -2,121,061 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -5,257,256 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 89,467 | USD | |
| At 2018-12-31 | 262 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 5,211,692 | USD | |
| At 2018-12-31 | 5,115,692 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 785,060 | USD | |
| At 2018-12-31 | 785,060 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 488,570 | USD | |
| At 2018-12-31 | 579,035 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,937,991 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 5,203,088 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 2,116,821 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 5,252,498 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 21,956 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 64,874 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -4,240 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -4,758 | USD | 273 |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -4,835,413 | USD | |
| At 2019-06-30 | -6,259,575 | USD | |
| At 2019-03-31 | -6,051,336 | USD | |
| At 2018-12-31 | -5,950,454 | USD | |
| At 2018-09-30 | -3,843,547 | USD | |
| At 2018-06-30 | -31,749,725 | USD | |
| At 2018-03-31 | -28,765,533 | USD | |
| At 2017-12-31 | -26,438,789 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 77,494 | USD | |
| At 2018-12-31 | 0 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 77,494 | USD | |
| At 2018-12-31 | 0 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 597,474 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 51,809 | USD | |
| At 2018-12-31 | 49,181 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 49,401 | USD | |
| At 2018-12-31 | 49,181 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 488,570 | USD | |
| At 2018-12-31 | 579,035 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 0 | USD | |
| At 2018-12-31 | 0 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -2,460,308 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -6,458,279 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 24,980,285 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 18,080,282 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 132 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 220 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 0 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 90,685 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 90,465 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 30,155 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 90,465 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 29,821 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 90,465 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -544,273 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -1,320,065 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 27,101,346 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 23,337,538 | USD | 273 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 0 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 0 | USD | 273 |
Proceeds from issuing common stock
Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 1,825,132 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 41,250 | USD | 273 |
Inspect the source
- Entity
- PARALLAX HEALTH SCIENCES, INC. / CIK 0001388410
- Captured
- SEC response SHA-256
94ef7b5cf30837ee48a9b3f8b759fe12b3da087f5b0a8ff4d38505bc8677ecf0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001388410.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))